Table 2.
Reference | Vitamin D Therapy/Supplementation Caused the Following Changes in the Levels of TSH, Thyroid Hormones and Thyroglobulin: | Vitamin D Therapy/Supplementation Caused the Following Changes in the Levels of Anti-Thyroid Antibodies: | Number of Participants | Diagnosis of Participants |
---|---|---|---|---|
[114] (meta-analysis) | ↔ TSH, ↔ fT4, ↔ fT3 | ↓TPOAb, ↔TgAb | 258 | Hashimoto’s thyroiditis |
[111] | ↓TSH, ↓fT3, ↓fT4, ↓Tg | ↓TPOAb, ↓TgAb | 11,017 | Participants in wellness program receiving vitamin D supplementation (2% hypothyroid and 22% subclinical hypothyroid) |
[113] | ↓TSH (in autoimmune thyroiditis positive group) | 198 | Autoimmune thyroiditis negative (103) and autoimmune thyroiditis positive (95) |
|
[115] | ↔TSH, ↔fT4 | ↓TPOAb | 100 | Patients with autoimmune thyroid disorder |
[116] | ↔TSH | ↔TPOAb, ↔TgAb | 34 | Female patients with Hashimoto’s thyroiditis |
[112] | ↓TSH, ↔T4, ↔T3 | 201 | Hypothyroid patients | |
[117] | Vitamin D/selenomethionine combination therapy caused: ↔TSH, ↔fT4, ↔fT3, ↓fT4/fT3 | Vitamin D/selenomethionine combination therapy caused: ↓TPOAb, ↓TgAb | 38 | Euthyroid women with Hashimoto’s thyroiditis |
[118] | Vitamin D/dehydroepiandrosterone(DHEA) combination therapy caused: ↓TSH, ↔fT4, ↔fT3 | Vitamin D therapy or vitamin D/dehydroepiandrosterone (DHEA) combination therapy caused: ↓TPOAb, ↓TgAb |
35 | Women with Hashimoto’s thyroiditis |
[119] | ↔TSH, ↔fT4, ↔fT3, ↔fT4/fT3 | ↓TPOAb, ↓TgAb | 62 | Women with Hashimoto’s thyroiditis |
[120] | ↔TSH | ↔TPOAb | 56 | Hashimoto’s thyroiditis |
[121] | ↓TSH, ↑T4 | 12 | Hypothyroid patients | |
[122] | ↔TSH, ↔fT4, ↔fT3 | ↓TPOAb, ↓TgAb | 59 | Non-lactating L-thyroxine-treated women with postpartum thyroiditis (38) and matched healthy postpartum women (21) |
[123] | ↔TSH, ↔fT4, ↔fT3 | ↓TPOAb, ↓TgAb | 57 | Levothyroxine-treated euthyroid women with Hashimoto’s thyroiditis and vitamin D insufficiency |
[124] | ↔TSH, ↔fT4, ↔fT3 | ↓TPOAb, ↓TgAb | 34 | Women with Hashimoto’s thyroiditis |
[125] | ↔TSH, ↔fT4, ↔fT3 | ↓TPOAb, ↓TgAb | 37 | Euthyroid men with autoimmune thyroiditis |
[126] | ↔TSH, ↔fT4, ↔fT3 | ↓TPOAb, ↓TgAb | 36 | Men with euthyroid Hashimoto’s thyroiditis and testosterone deficiency |
[73] | Vitamin D/metformin combination therapy caused: ↓TSH, ↔fT4, ↔fT3 |
Vitamin D/ metformin combination therapy caused: ↓TPOAb, ↓TgAb |
32 | Women with Hashimoto’s thyroiditis |
[127] | ↓TSH (in patients receiving vitamin D supplementation), ↔T4, ↔T3 | ↔TPOAb, ↓TgAb (in patients receiving vitamin D supplementation) |
40 | Female patients with Hashimoto’s thyroiditis |
This table includes only studies conducted in human subjects. (↔) no effect, (↓) decrease, (↑) increase. fT3, free triiodothyronine; fT4, free thyroxine; T3, triiodothyronine; T4, thyroxine; Tg, thyroglobulin; TgAb, anti-thyroglobulin antibody; TPOAb, anti-thyroid peroxidase antibody; TSH, thyroid stimulating hormone; tT3, total T3; tT4, total T4.